Amyloidosis TTR-Wild Type Patients In New Zealand

1 Views

11/23/23

TTR amyloidosis is a debilitating disease that if not diagnosed at the early stages, will cause the condition of the sufferers to deteriorate further until the point of death. Listen to two patients from New Zealand share their diagnosis experience, how having the disease has impacted their life and understand that amyloidosis wild type can effect anyone, including you. It is a silent killer. Lets bring awareness and proper education to the masses so correct treatment can be provided. John waited almost 18 years before he got help.

Thank you to the patients for freely sharing their experience for the benefit of others. We also thank our supporters Akcea Therapeutics and Eidos Bridgebio for making this awareness video possible.